Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Quezada SA"" wg kryterium: Autor


Tytuł :
Immune Surveillance in Clinical Regression of Preinvasive Squamous Cell Lung Cancer.
Autorzy :
Pennycuick A; Lungs for Living Research Centre, UCL Respiratory, University College London, London, United Kingdom.
Teixeira VH; Lungs for Living Research Centre, UCL Respiratory, University College London, London, United Kingdom.
AbdulJabbar K; Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom.; Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom.
Raza SEA; Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom.; Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom.; Department of Computer Science, University of Warwick, Coventry, United Kingdom.
Lund T; Cancer Immunology Unit, University College London Cancer Institute, University College London, London, United Kingdom.; Research Department of Haematology, University College London Cancer Institute, University College London, London, United Kingdom.; UCL Manchester Lung Cancer Centre of Excellence, London, United Kingdom.
Akarca AU; Department of Cellular Pathology, University College London Hospital, London, United Kingdom.
Rosenthal R; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, United Kingdom.
Kalinke L; Lungs for Living Research Centre, UCL Respiratory, University College London, London, United Kingdom.
Chandrasekharan DP; Lungs for Living Research Centre, UCL Respiratory, University College London, London, United Kingdom.
Pipinikas CP; University College London Cancer Institute, London, United Kingdom.
Lee-Six H; The Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, United Kingdom.
Hynds RE; Lungs for Living Research Centre, UCL Respiratory, University College London, London, United Kingdom.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, United Kingdom.; University College London Cancer Institute, London, United Kingdom.
Gowers KHC; Lungs for Living Research Centre, UCL Respiratory, University College London, London, United Kingdom.
Henry JY; Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom.; Cancer Immunology Unit, University College London Cancer Institute, University College London, London, United Kingdom.
Millar FR; Cancer Research UK Edinburgh Centre, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, United Kingdom.
Hagos YB; Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom.; Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom.
Denais C; Lungs for Living Research Centre, UCL Respiratory, University College London, London, United Kingdom.
Falzon M; Department of Cellular Pathology, University College London Hospital, London, United Kingdom.
Moore DA; UCL Manchester Lung Cancer Centre of Excellence, London, United Kingdom.; Department of Cellular Pathology, University College London Hospital, London, United Kingdom.
Antoniou S; Lungs for Living Research Centre, UCL Respiratory, University College London, London, United Kingdom.
Durrenberger PF; Lungs for Living Research Centre, UCL Respiratory, University College London, London, United Kingdom.
Furness AJ; Cancer Immunology Unit, University College London Cancer Institute, University College London, London, United Kingdom.; The Royal Marsden NHS Foundation Trust, London, United Kingdom.
Carroll B; Lungs for Living Research Centre, UCL Respiratory, University College London, London, United Kingdom.
Marceaux C; Personalised Oncology Division, The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia.
Asselin-Labat ML; Personalised Oncology Division, The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia.; Knight Cancer Institute, Cancer Early Detection and Advanced Research (CEDAR) Center, Oregon Health & Science University, Portland, Oregon.
Larson W; Knight Cancer Institute, Department of Cell, Developmental and Cancer Biology, Oregon Health & Science University, Portland, Oregon.
Betts C; Knight Cancer Institute, Department of Cell, Developmental and Cancer Biology, Oregon Health & Science University, Portland, Oregon.
Coussens LM; Knight Cancer Institute, Department of Cell, Developmental and Cancer Biology, Oregon Health & Science University, Portland, Oregon.
Thakrar RM; Lungs for Living Research Centre, UCL Respiratory, University College London, London, United Kingdom.
George J; Lungs for Living Research Centre, UCL Respiratory, University College London, London, United Kingdom.
Swanton C; UCL Manchester Lung Cancer Centre of Excellence, London, United Kingdom.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, United Kingdom.; University College London Cancer Institute, London, United Kingdom.
Thirlwell C; University College London Cancer Institute, London, United Kingdom.; University of Exeter College of Medicine and Health, Exeter, United Kingdom.
Campbell PJ; The Wellcome Trust Sanger Institute, Hinxton, Cambridgeshire, United Kingdom.
Marafioti T; Department of Cellular Pathology, University College London Hospital, London, United Kingdom.
Yuan Y; Centre for Evolution and Cancer, The Institute of Cancer Research, London, United Kingdom.; Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom.
Quezada SA; Cancer Immunology Unit, University College London Cancer Institute, University College London, London, United Kingdom.; Research Department of Haematology, University College London Cancer Institute, University College London, London, United Kingdom.; UCL Manchester Lung Cancer Centre of Excellence, London, United Kingdom.
McGranahan N; University College London Cancer Institute, London, United Kingdom. .; Cancer Genome Evolution Research Group, University College London Cancer Institute, London, United Kingdom.
Janes SM; Lungs for Living Research Centre, UCL Respiratory, University College London, London, United Kingdom. .; UCL Manchester Lung Cancer Centre of Excellence, London, United Kingdom.
Pokaż więcej
Źródło :
Cancer discovery [Cancer Discov] 2020 Oct; Vol. 10 (10), pp. 1489-1499. Date of Electronic Publication: 2020 Jul 20.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
The Great Debate at 'Immunotherapy Bridge', Naples, December 5, 2019.
Autorzy :
Ascierto PA; Cancer Unit of Melanoma, Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy .
Bifulco C; Earle A. Chiles Research Institute, Robert W. Franz Cancer Research Center, Providence Portland Medical Center, Portland, Oregon, USA.
Galon J; Laboratory of Integrative Cancer Immunology, Equipe Labellisée Ligue Contre le Cancer, Centre de Recherche des Cordeliers, INSERM, Paris, Île-de-France, France.
Garbe C; Center for Dermatooncology, Department of Dermatology, Eberhard Karls University Tübingen, Tubingen, Baden-Württemberg, Germany.
Khleif SN; The Loop Immuno-Oncology Research Laboratory, Lombardi Cancer Center, Georgetown University, Washington, District of Columbia, USA.
McQuade J; Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Odunsi K; Center for Immunotherapy and Department of Gynaecologic Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.
Okada H; Department of Neurological Surgery, Parker Institute for Cancer Immunotherapy, UCSF, San Francisco, California, USA.
Paulos CM; Department of Microbiology and Immunology Hollings Cancer Center, MUSC, Charleston, South Carolina, USA.
Quezada SA; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK.
Tawbi HA; Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Timmerman J; Santa Monica UCLA Medical Center, University of California Los Angeles, Los Angeles, California, USA.
Trinchieri G; Laboratory of Integrative Cancer Immunology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Butterfield LH; PICI Research and Development, Parker Institute for Cancer Immunotherapy, UCSF, San Francisco, California, USA.
Puzanov I; Early Phase Clinical Trials Program, Developmental Therapeutics Program, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.
Pokaż więcej
Źródło :
Journal for immunotherapy of cancer [J Immunother Cancer] 2020 Aug; Vol. 8 (2).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Escape from nonsense-mediated decay associates with anti-tumor immunogenicity.
Autorzy :
Litchfield K; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK. .; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, 72 Huntley Street, London, WC1E 6DD, UK. .
Reading JL; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, 72 Huntley Street, London, WC1E 6DD, UK.; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, Paul O'Gorman Building, 72 Huntley Street, London, WC1E 6BT, UK.
Lim EL; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK.
Xu H; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK.
Liu P; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK.
Al-Bakir M; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK.
Wong YNS; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, Paul O'Gorman Building, 72 Huntley Street, London, WC1E 6BT, UK.
Rowan A; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK.
Funt SA; Memorial Sloan Kettering Cancer Center, Division of Solid Tumor Oncology, Department of Medicine, Weill Cornell Medical College, and Parker Center for Cancer Immunotherapy, 885 2nd Avenue, New York, NY, 10017, USA.
Merghoub T; Memorial Sloan Kettering Cancer Center, Division of Solid Tumor Oncology, Department of Medicine, Weill Cornell Medical College, and Parker Center for Cancer Immunotherapy, 885 2nd Avenue, New York, NY, 10017, USA.
Perkins D; Mass Spectrometry Proteomics, The Francis Crick Institute, London, NW1 1AT, UK.
Lauss M; Faculty of Medicine, Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Scheelegatan 2, Medicon Village, 22185, Lund, Sweden.
Svane IM; Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital Herlev, Borgmester Ib Juuls Vej 1, 2730, Herlev, Denmark.
Jönsson G; Faculty of Medicine, Division of Oncology and Pathology, Department of Clinical Sciences Lund, Lund University, Scheelegatan 2, Medicon Village, 22185, Lund, Sweden.
Herrero J; Bill Lyons Informatics Centre, University College London Cancer Institute, London, WC1E 6DD, UK.
Larkin J; Renal and Skin Units, The Royal Marsden Hospital, London, SW3 6JJ, UK.
Quezada SA; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, Paul O'Gorman Building, 72 Huntley Street, London, WC1E 6BT, UK.
Hellmann MD; Memorial Sloan Kettering Cancer Center, Division of Solid Tumor Oncology, Department of Medicine, Weill Cornell Medical College, and Parker Center for Cancer Immunotherapy, 885 2nd Avenue, New York, NY, 10017, USA.
Turajlic S; Renal and Skin Units, The Royal Marsden Hospital, London, SW3 6JJ, UK. .; Cancer Dynamics Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK. .
Swanton C; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, UK. .; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, Paul O'Gorman Building, 72 Huntley Street, London, WC1E 6DD, UK. .; Department of Medical Oncology, University College London Hospitals, 235 Euston Rd, Fitzrovia, London, NW1 2BU, UK. .
Pokaż więcej
Źródło :
Nature communications [Nat Commun] 2020 Jul 30; Vol. 11 (1), pp. 3800. Date of Electronic Publication: 2020 Jul 30.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Melanoma/*genetics
Melanoma/*immunology
Nonsense Mediated mRNA Decay/*genetics
T-Lymphocytes/*immunology
Tumor Escape/*genetics
Adoptive Transfer ; Antigens, Neoplasm/immunology ; Biomarkers, Tumor/genetics ; Frameshift Mutation/genetics ; Humans ; INDEL Mutation/genetics ; Immunotherapy, Adoptive ; T-Lymphocytes/transplantation ; Whole Exome Sequencing
Czasopismo naukowe
Tytuł :
Geospatial immune variability illuminates differential evolution of lung adenocarcinoma.
Autorzy :
AbdulJabbar K; Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; Division of Molecular Pathology, The Institute of Cancer Research, London, UK.
Raza SEA; Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; Division of Molecular Pathology, The Institute of Cancer Research, London, UK.
Rosenthal R; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
Jamal-Hanjani M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Department of Medical Oncology, University College London Hospitals NHS Foundation Trust, London, UK.
Veeriah S; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
Akarca A; Department of Cellular Pathology, University College London, University College Hospital, London, UK.
Lund T; Translational Immune Oncology Group, Centre for Molecular Medicine, Royal Marsden Hospital NHS Trust, London, UK.
Moore DA; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Department of Cellular Pathology, University College London, University College Hospital, London, UK.
Salgado R; Department of Pathology, GZA-ZNA-Ziekenhuizen, Antwerp, Belgium.; Division of Research, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia.
Al Bakir M; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
Zapata L; Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.; Division of Molecular Pathology, The Institute of Cancer Research, London, UK.
Hiley CT; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
Officer L; MRC Toxicology Unit, University of Cambridge, Leicester, UK.
Sereno M; Leicester Cancer Research Centre, University of Leicester, Leicester, UK.
Smith CR; Leicester Cancer Research Centre, University of Leicester, Leicester, UK.
Loi S; Division of Research, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia.
Hackshaw A; Cancer Research UK & University College London Cancer Trials Centre, University College London, London, UK.
Marafioti T; Department of Cellular Pathology, University College London, University College Hospital, London, UK.
Quezada SA; Cancer Immunology Unit, University College London Cancer Institute, London, UK.
McGranahan N; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Genome Evolution Research Group, University College London Cancer Institute, University College London, London, UK.
Le Quesne J; MRC Toxicology Unit, University of Cambridge, Leicester, UK. .; Leicester Cancer Research Centre, University of Leicester, Leicester, UK. .; Glenfield Hospital, University Hospitals Leicester NHS Trust, Leicester, UK. .
Swanton C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. .; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK. .; Department of Medical Oncology, University College London Hospitals NHS Foundation Trust, London, UK. .
Yuan Y; Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK. .; Division of Molecular Pathology, The Institute of Cancer Research, London, UK. .
Pokaż więcej
Corporate Authors :
TRACERx Consortium
Źródło :
Nature medicine [Nat Med] 2020 Jul; Vol. 26 (7), pp. 1054-1062. Date of Electronic Publication: 2020 May 27.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Adenocarcinoma of Lung/*genetics
Antigens, Neoplasm/*genetics
Carcinoma, Non-Small-Cell Lung/*genetics
Neoplasm Recurrence, Local/*genetics
Adenocarcinoma of Lung/immunology ; Adenocarcinoma of Lung/pathology ; Antigens, Neoplasm/immunology ; Biomarkers, Tumor/genetics ; Carcinoma, Non-Small-Cell Lung/immunology ; Carcinoma, Non-Small-Cell Lung/pathology ; Deep Learning ; Exome/genetics ; Female ; Humans ; Male ; Middle Aged ; Mutation/genetics ; Neoplasm Recurrence, Local/immunology ; Neoplasm Recurrence, Local/pathology ; Neoplasm Staging ; RNA-Seq ; Recurrence ; Tumor Microenvironment/genetics ; Tumor Microenvironment/immunology ; Whole Exome Sequencing
Czasopismo naukowe
Tytuł :
Marrow-Infiltrating Regulatory T Cells Correlate with the Presence of Dysfunctional CD4 Cells and Inferior Survival in Patients with Newly Diagnosed Multiple Myeloma.
Autorzy :
Alrasheed N; Research Department of Haematology, University College London Cancer Institute, London, United Kingdom.
Lee L; Research Department of Haematology, University College London Cancer Institute, London, United Kingdom.
Ghorani E; Research Department of Haematology, University College London Cancer Institute, London, United Kingdom.; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, United Kingdom.
Henry JY; Research Department of Haematology, University College London Cancer Institute, London, United Kingdom.; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, United Kingdom.
Conde L; Bill Lyons Informatics Centre, University College London Cancer Institute, London, United Kingdom.
Chin M; Research Department of Haematology, University College London Cancer Institute, London, United Kingdom.
Galas-Filipowicz D; Research Department of Haematology, University College London Cancer Institute, London, United Kingdom.
Furness AJS; Research Department of Haematology, University College London Cancer Institute, London, United Kingdom.; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, United Kingdom.
Chavda SJ; Research Department of Haematology, University College London Cancer Institute, London, United Kingdom.
Richards H; Research Department of Haematology, University College London Cancer Institute, London, United Kingdom.
De-Silva D; Research Department of Haematology, University College London Cancer Institute, London, United Kingdom.
Cohen OC; University College London Hospitals NHS Foundation Trust, London, United Kingdom.
Patel D; Department of Histopathology, University College London, London, United Kingdom.
Brooks A; Institute of Child Health, University College London, London, United Kingdom.
Rodriguez-Justo M; Department of Histopathology, University College London, London, United Kingdom.
Pule M; Research Department of Haematology, University College London Cancer Institute, London, United Kingdom.
Herrero J; Bill Lyons Informatics Centre, University College London Cancer Institute, London, United Kingdom.
Quezada SA; Research Department of Haematology, University College London Cancer Institute, London, United Kingdom. s.quezada@ucl.ac.uk .; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, United Kingdom.
Yong KL; Research Department of Haematology, University College London Cancer Institute, London, United Kingdom. s.quezada@ucl.ac.uk .
Pokaż więcej
Źródło :
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2020 Jul 01; Vol. 26 (13), pp. 3443-3454. Date of Electronic Publication: 2020 Mar 27.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Publisher Correction: Spatial heterogeneity of the T cell receptor repertoire reflects the mutational landscape in lung cancer.
Autorzy :
Joshi K; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK.; Department of Medical Oncology, The Royal Marsden NHS Foundation Trust, London, UK.
de Massy MR; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK.
Ismail M; Division of Infection and Immunity, University College London, London, UK.
Reading JL; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK.
Uddin I; Division of Infection and Immunity, University College London, London, UK.
Woolston A; Division of Infection and Immunity, University College London, London, UK.
Hatipoglu E; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK.; Department of Medical Oncology, The Royal Marsden NHS Foundation Trust, London, UK.
Oakes T; Division of Infection and Immunity, University College London, London, UK.
Rosenthal R; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Bill Lyons Informatics Centre, University College London Cancer Institute, London, UK.
Peacock T; Division of Infection and Immunity, University College London, London, UK.; Computation, Mathematics and Physics in the Life Sciences and Experimental Biology, Department of Computer Science, University College London, London, UK.
Ronel T; Division of Infection and Immunity, University College London, London, UK.
Noursadeghi M; Division of Infection and Immunity, University College London, London, UK.
Turati V; Department of Cancer Biology, University College London Cancer Institute, London, UK.
Furness AJS; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK.; Department of Medical Oncology, The Royal Marsden NHS Foundation Trust, London, UK.
Georgiou A; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK.
Wong YNS; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK.
Ben Aissa A; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Sunderland MW; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK.
Jamal-Hanjani M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Veeriah S; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Birkbak NJ; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
Wilson GA; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
Hiley CT; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Ghorani E; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK.
Guerra-Assunção JA; Bill Lyons Informatics Centre, University College London Cancer Institute, London, UK.
Herrero J; Bill Lyons Informatics Centre, University College London Cancer Institute, London, UK.
Enver T; University College London Cancer Institute, London, UK.
Hadrup SR; Department of Health Technology, Technical University of Denmark, Lyngby, Denmark.
Hackshaw A; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Peggs KS; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK.
McGranahan N; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Swanton C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. .; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK. .
Quezada SA; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK. s.quezada@ucl.ac.uk.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. s.quezada@ucl.ac.uk.
Chain B; Division of Infection and Immunity, University College London, London, UK. .; Department of Computer Sciences, University College London, London, UK. .
Pokaż więcej
Corporate Authors :
TRACERx consortium
Źródło :
Nature medicine [Nat Med] 2020 Jul; Vol. 26 (7), pp. 1148.
Typ publikacji :
Published Erratum
Tytuł :
The T cell differentiation landscape is shaped by tumour mutations in lung cancer.
Autorzy :
Ghorani E; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, WC1E 6BT, United Kingdom.; Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London WC1E 6BT, United Kingdom.
Reading JL; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, WC1E 6BT, United Kingdom.; Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London WC1E 6BT, United Kingdom.
Henry JY; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, WC1E 6BT, United Kingdom.; Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London WC1E 6BT, United Kingdom.
de Massy MR; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, WC1E 6BT, United Kingdom.; Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London WC1E 6BT, United Kingdom.
Rosenthal R; Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London WC1E 6BT, United Kingdom.
Turati V; Department of Cancer Biology, University College London Cancer Institute, London, WC1E 6BT, United Kingdom.
Joshi K; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, WC1E 6BT, United Kingdom.; Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London WC1E 6BT, United Kingdom.
Furness AJS; Department of Medical Oncology, The Royal Marsden NHS Foundation Trust, London, SW3 6JJ, United Kingdom.
Aissa AB; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, WC1E 6BT, United Kingdom.; Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London WC1E 6BT, United Kingdom.
Saini SK; Department of Health Technology, Technical University of Denmark, Lyngby, Denmark.
Ramskov S; Department of Health Technology, Technical University of Denmark, Lyngby, Denmark.
Georgiou A; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, WC1E 6BT, United Kingdom.; Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London WC1E 6BT, United Kingdom.
Sunderland MW; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, WC1E 6BT, United Kingdom.; Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London WC1E 6BT, United Kingdom.
Wong YNS; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, WC1E 6BT, United Kingdom.; Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London WC1E 6BT, United Kingdom.
De Mucha MV; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, WC1E 6BT, United Kingdom.; Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London WC1E 6BT, United Kingdom.
Day W; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, WC1E 6BT, United Kingdom.; Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London WC1E 6BT, United Kingdom.
Galvez-Cancino F; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, WC1E 6BT, United Kingdom.; Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London WC1E 6BT, United Kingdom.
Becker PD; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, WC1E 6BT, United Kingdom.; Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London WC1E 6BT, United Kingdom.
Uddin I; Division of Infection and Immunity, University College London, London, WC1E 6BT, United Kingdom.
Ismail M; Division of Infection and Immunity, University College London, London, WC1E 6BT, United Kingdom.
Ronel T; Division of Infection and Immunity, University College London, London, WC1E 6BT, United Kingdom.
Woolston A; Division of Infection and Immunity, University College London, London, WC1E 6BT, United Kingdom.
Jamal-Hanjani M; Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London WC1E 6BT, United Kingdom.
Veeriah S; Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London WC1E 6BT, United Kingdom.
Birkbak NJ; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, United Kingdom.
Wilson GA; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, United Kingdom.
Litchfield K; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, United Kingdom.
Conde L; Bill Lyons Informatics Centre, UCL Cancer Institute, London WC1E 6BT, United Kingdom.
Guerra-Assunção JA; Bill Lyons Informatics Centre, UCL Cancer Institute, London WC1E 6BT, United Kingdom.
Blighe K; Bill Lyons Informatics Centre, UCL Cancer Institute, London WC1E 6BT, United Kingdom.
Biswas D; Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London WC1E 6BT, United Kingdom.
Salgado R; Department of Pathology, GZA-ZNA, Antwerp, Belgium.
Lund T; Department of Medical Oncology, The Royal Marsden NHS Foundation Trust, London, SW3 6JJ, United Kingdom.
Al Bakir M; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, United Kingdom.
Moore DA; Department of Pathology, UCL Cancer Institute, London, UK.
Hiley CT; Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London WC1E 6BT, United Kingdom.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, United Kingdom.
Loi S; Division of Research Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia.
Sun Y; Division of Infection and Immunity, University College London, London, WC1E 6BT, United Kingdom.
Yuan Y; Department of Medical Oncology, The Royal Marsden NHS Foundation Trust, London, SW3 6JJ, United Kingdom.
AbdulJabbar K; Department of Medical Oncology, The Royal Marsden NHS Foundation Trust, London, SW3 6JJ, United Kingdom.
Turajilic S; Department of Medical Oncology, The Royal Marsden NHS Foundation Trust, London, SW3 6JJ, United Kingdom.
Herrero J; Bill Lyons Informatics Centre, UCL Cancer Institute, London WC1E 6BT, United Kingdom.
Enver T; Department of Cancer Biology, University College London Cancer Institute, London, WC1E 6BT, United Kingdom.
Hadrup SR; Department of Health Technology, Technical University of Denmark, Lyngby, Denmark.
Hackshaw A; Cancer Research UK & UCL Cancer Trials Centre, London, United Kingdom.
Peggs KS; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, WC1E 6BT, United Kingdom.
McGranahan N; Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London WC1E 6BT, United Kingdom.
Chain B; Division of Infection and Immunity, University College London, London, WC1E 6BT, United Kingdom.; Department of Computer Sciences, University College London, London, WC1E 6BT, United Kingdom.
Swanton C; Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London WC1E 6BT, United Kingdom.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, 1 Midland Rd, London, NW1 1AT, United Kingdom.; University College London Hospitals, London, United Kingdom.
Quezada SA; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, WC1E 6BT, United Kingdom.; Cancer Research UK Lung Cancer Centre of Excellence, UCL Cancer Institute, London WC1E 6BT, United Kingdom.
Pokaż więcej
Źródło :
Nature cancer [Nat Cancer] 2020 May; Vol. 1 (5), pp. 546-561. Date of Electronic Publication: 2020 May 22.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Regulatory T Cells Restrain Interleukin-2- and Blimp-1-Dependent Acquisition of Cytotoxic Function by CD4 T Cells.
Autorzy :
Śledzińska A; Cancer Immunology Unit, UCL Cancer Institute, University College London, London WC1E 6DD, UK; Research Department of Haematology, University College London, Cancer Institute, London WC1E 6DD, UK.
Vila de Mucha M; Cancer Immunology Unit, UCL Cancer Institute, University College London, London WC1E 6DD, UK; Regulatory Genomics Research Group, UCL Cancer Institute, University College London, London WC1E 6DD, UK.
Bergerhoff K; Cancer Immunology Unit, UCL Cancer Institute, University College London, London WC1E 6DD, UK; Research Department of Haematology, University College London, Cancer Institute, London WC1E 6DD, UK.
Hotblack A; Research Department of Haematology, University College London, Cancer Institute, London WC1E 6DD, UK.
Demane DF; Cancer Immunology Unit, UCL Cancer Institute, University College London, London WC1E 6DD, UK; Research Department of Haematology, University College London, Cancer Institute, London WC1E 6DD, UK.
Ghorani E; Cancer Immunology Unit, UCL Cancer Institute, University College London, London WC1E 6DD, UK; Research Department of Haematology, University College London, Cancer Institute, London WC1E 6DD, UK.
Akarca AU; Department of Cellular Pathology, University College London Hospital, London NW1 2BU, UK.
Marzolini MAV; Cancer Immunology Unit, UCL Cancer Institute, University College London, London WC1E 6DD, UK; Research Department of Haematology, University College London, Cancer Institute, London WC1E 6DD, UK.
Solomon I; Cancer Immunology Unit, UCL Cancer Institute, University College London, London WC1E 6DD, UK; Research Department of Haematology, University College London, Cancer Institute, London WC1E 6DD, UK.
Vargas FA; Cancer Immunology Unit, UCL Cancer Institute, University College London, London WC1E 6DD, UK; Research Department of Haematology, University College London, Cancer Institute, London WC1E 6DD, UK.
Pule M; Research Department of Haematology, University College London, Cancer Institute, London WC1E 6DD, UK.
Ono M; Faculty of Natural Sciences, Department of Life Sciences, Imperial College London, London SW7 2BB, UK.
Seddon B; Institute of Immunity and Transplantation, Department of Immunology, Royal Free Hospital, London NW3 2PF, UK.
Kassiotis G; Retroviral Immunology Laboratory, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK.
Ariyan CE; Memorial Sloan Kettering Center, 1275 York Avenue, New York, NY 10065, USA.
Korn T; Department of Experimental Neuroimmunology, Klinikum rechts der Isar, Technical University of Munich, 81675 Munich, Germany.
Marafioti T; Department of Cellular Pathology, University College London Hospital, London NW1 2BU, UK.
Lord GM; Faculty of Biology, Medicine and Health, University of Manchester, 46 Grafton Street, Manchester M13 9NT, UK.
Stauss H; Institute of Immunity and Transplantation, Department of Immunology, Royal Free Hospital, London NW3 2PF, UK.
Jenner RG; Regulatory Genomics Research Group, UCL Cancer Institute, University College London, London WC1E 6DD, UK.
Peggs KS; Cancer Immunology Unit, UCL Cancer Institute, University College London, London WC1E 6DD, UK; Research Department of Haematology, University College London, Cancer Institute, London WC1E 6DD, UK. Electronic address: .
Quezada SA; Cancer Immunology Unit, UCL Cancer Institute, University College London, London WC1E 6DD, UK; Research Department of Haematology, University College London, Cancer Institute, London WC1E 6DD, UK. Electronic address: s.quezada@ucl.ac.uk.
Pokaż więcej
Źródło :
Immunity [Immunity] 2020 Jan 14; Vol. 52 (1), pp. 151-166.e6. Date of Electronic Publication: 2020 Jan 07.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Granzymes/*immunology
Neoplasms/*immunology
Positive Regulatory Domain I-Binding Factor 1/*metabolism
T-Box Domain Proteins/*metabolism
T-Lymphocytes, Regulatory/*immunology
T-Lymphocytes, Regulatory/*transplantation
Adoptive Transfer ; Animals ; Cell Line, Tumor ; Humans ; Interferon-gamma/immunology ; Interleukin-2/metabolism ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; T-Lymphocytes, Regulatory/cytology ; Tumor Microenvironment/immunology
Czasopismo naukowe
Tytuł :
Tumour Dormancy and Reawakening: Opportunities and Challenges.
Autorzy :
Boire A; Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Manhattan, NY 10065, USA. Electronic address: .
Coffelt SB; Cancer Research UK Beatson Institute, Bearsden, Glasgow, G61 1BD, UK; Institute of Cancer Sciences, University of Glasgow, Bearsden, Glasgow, G61 1QH, UK.
Quezada SA; UCL Cancer Institute, University College London, Gower Street, London, WC1E 6BT, UK.
Vander Heiden MG; Koch Institute for Integrative Cancer Research at MIT, Massachusetts Institute of Technology, Cambridge, MA 02142, USA.
Weeraratna AT; Johns Hopkins Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205, USA; Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Hospital, Baltimore, MD 21231, USA.
Pokaż więcej
Źródło :
Trends in cancer [Trends Cancer] 2019 Dec; Vol. 5 (12), pp. 762-765. Date of Electronic Publication: 2019 Nov 25.
Typ publikacji :
Case Reports; Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
Neoplasms/*pathology
Humans ; Neoplasm Metastasis
Czasopismo naukowe
Tytuł :
Spatial heterogeneity of the T cell receptor repertoire reflects the mutational landscape in lung cancer.
Autorzy :
Joshi K; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK.; Department of Medical Oncology, The Royal Marsden NHS Foundation Trust, London, UK.
de Massy MR; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK.
Ismail M; Division of Infection and Immunity, University College London, London, UK.
Reading JL; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK.
Uddin I; Division of Infection and Immunity, University College London, London, UK.
Woolston A; Division of Infection and Immunity, University College London, London, UK.
Hatipoglu E; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK.; Department of Medical Oncology, The Royal Marsden NHS Foundation Trust, London, UK.
Oakes T; Division of Infection and Immunity, University College London, London, UK.
Rosenthal R; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Bill Lyons Informatics Centre, University College London Cancer Institute, London, UK.
Peacock T; Division of Infection and Immunity, University College London, London, UK.; Computation, Mathematics and Physics in the Life Sciences and Experimental Biology, Department of Computer Science, University College London, London, UK.
Ronel T; Division of Infection and Immunity, University College London, London, UK.
Noursadeghi M; Division of Infection and Immunity, University College London, London, UK.
Turati V; Department of Cancer Biology, University College London Cancer Institute, London, UK.
Furness AJS; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK.; Department of Medical Oncology, The Royal Marsden NHS Foundation Trust, London, UK.
Georgiou A; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK.
Wong YNS; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK.
Ben Aissa A; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Sunderland MW; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK.
Jamal-Hanjani M; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Veeriah S; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Birkbak NJ; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
Wilson GA; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK.
Hiley CT; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Ghorani E; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK.
Guerra-Assunção JA; Bill Lyons Informatics Centre, University College London Cancer Institute, London, UK.
Herrero J; Bill Lyons Informatics Centre, University College London Cancer Institute, London, UK.
Enver T; University College London Cancer Institute, London, UK.
Hadrup SR; Department of Health Technology, Technical University of Denmark, Lyngby, Denmark.
Hackshaw A; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Peggs KS; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK.
McGranahan N; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK.
Swanton C; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. .; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK. .
Quezada SA; Cancer Immunology Unit, Research Department of Haematology, University College London Cancer Institute, London, UK. s.quezada@ucl.ac.uk.; Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UK. s.quezada@ucl.ac.uk.
Chain B; Division of Infection and Immunity, University College London, London, UK. .; Department of Computer Sciences, University College London, London, UK. .
Pokaż więcej
Corporate Authors :
TRACERx consortium
Źródło :
Nature medicine [Nat Med] 2019 Oct; Vol. 25 (10), pp. 1549-1559. Date of Electronic Publication: 2019 Oct 07.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Genetic Heterogeneity*
Immunotherapy, Adoptive*
Carcinoma, Non-Small-Cell Lung/*genetics
Receptors, Antigen, T-Cell/*genetics
Aged ; CD8-Positive T-Lymphocytes/immunology ; CD8-Positive T-Lymphocytes/pathology ; Carcinoma, Non-Small-Cell Lung/immunology ; Carcinoma, Non-Small-Cell Lung/pathology ; Carcinoma, Non-Small-Cell Lung/therapy ; Female ; Humans ; Lymphocytes, Tumor-Infiltrating/immunology ; Lymphocytes, Tumor-Infiltrating/pathology ; Male ; Middle Aged ; Mutation ; Receptors, Antigen, T-Cell/immunology
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies